136 related articles for article (PubMed ID: 9129986)
1. HLA-B8,DR3 haplotype affects lymphocyte blood levels.
Caruso C; Bongiardina C; Candore G; Cigna D; Romano GC; Colucci AT; Di Lorenzo G; Gervasi F; Manno M; Potestio M; Tantillo G
Immunol Invest; 1997 Apr; 26(3):333-40. PubMed ID: 9129986
[TBL] [Abstract][Full Text] [Related]
2. T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.
Candore G; Cigna D; Todaro M; De Maria R; Stassi G; Giordano C; Caruso C
Hum Immunol; 1995 Apr; 42(4):289-94. PubMed ID: 7558912
[TBL] [Abstract][Full Text] [Related]
3. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.
Stassi G; Todaro M; De Maria R; Candore G; Cigna D; Caruso C; Galluzzo A; Giordano C
Hum Immunol; 1997 Jun; 55(1):39-45. PubMed ID: 9328788
[TBL] [Abstract][Full Text] [Related]
4. Individual susceptibility to hexavalent chromium of workers of shoe, hide, and leather industries. Immunological pattern of HLA-B8, DR3-positive subjects.
Mignini F; Streccioni V; Baldo M; Vitali M; Indraccolo U; Bernacchia G; Cocchioni M
Prev Med; 2004 Oct; 39(4):767-75. PubMed ID: 15351544
[TBL] [Abstract][Full Text] [Related]
5. HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.
Modica MA; Cammarata G; Caruso C
J Immunogenet; 1990; 17(1-2):101-7. PubMed ID: 2212697
[TBL] [Abstract][Full Text] [Related]
6. Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype.
Colucci AT; Di Lorenzo G; Ingrassia A; Crescimanno G; Modica MA; Candore G; Caruso C
Exp Clin Immunogenet; 1992; 9(2):72-9. PubMed ID: 1489552
[TBL] [Abstract][Full Text] [Related]
7. In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals implications for immunoglobulin A synthesis dysfunction.
Lio D; D'Anna C; Gervasi F; Cigna D; Modica MA; Candore G; Caruso C
Hum Immunol; 1995 Nov; 44(3):170-4. PubMed ID: 8666553
[TBL] [Abstract][Full Text] [Related]
8. Natural killer and lymphokine-activated killer activity in HLA-B8,DR3-positive subjects.
Caruso C; Candore G; Colucci AT; Cigna D; Modica MA; Tantillo G; Salerno A
Hum Immunol; 1993 Nov; 38(3):226-30. PubMed ID: 8106282
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor secretion defect in vitro in HLA-B8, DR3 positive subjects.
Modica MA; di Lorenzo G; Galluzzo A; Giordano C; Portelli MR; Candore G; Caruso C
Autoimmunity; 1990; 7(2-3):87-96. PubMed ID: 2104185
[TBL] [Abstract][Full Text] [Related]
10. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression.
Collier PM; Wojnarowska F; Welsh K; McGuire W; Black MM
Br J Dermatol; 1999 Nov; 141(5):867-75. PubMed ID: 10583169
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytokine production by HLA-B8,DR3 positive subjects.
Candore G; Cigna D; Gervasi F; Colucci AT; Modica MA; Caruso C
Autoimmunity; 1994; 18(2):121-32. PubMed ID: 7742473
[TBL] [Abstract][Full Text] [Related]
12. Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe.
Witt CS; Price P; Kaur G; Cheong K; Kanga U; Sayer D; Christiansen F; Mehra NK
Tissue Antigens; 2002 Dec; 60(6):474-80. PubMed ID: 12542740
[TBL] [Abstract][Full Text] [Related]
13. HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2.
Candore G; Colucci AT; Modica MA; Caruso C
Immunopharmacol Immunotoxicol; 1991; 13(4):551-61. PubMed ID: 1774436
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin genes, HLA-B8/DR3, and immune responsiveness to primary immunogen and mitogens in normal subjects.
Kallenberg CG; Klaassen RJ; Westra J; Beelen JM; Ockhuizen T
Clin Immunol Immunopathol; 1988 Jun; 47(3):333-42. PubMed ID: 3259481
[TBL] [Abstract][Full Text] [Related]
15. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.
Tait B; Mackay IR; Board P; Coggan M; Emery P; Eckardt G
Gastroenterology; 1989 Aug; 97(2):479-81. PubMed ID: 2787258
[TBL] [Abstract][Full Text] [Related]
16. DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
Bishof NA; Welch TR; Beischel LS; Carson D; Donnelly PA
Pediatr Nephrol; 1993 Jun; 7(3):243-6. PubMed ID: 8100139
[TBL] [Abstract][Full Text] [Related]
17. Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates.
McCombs CC; Michalski JP; deShazo R; Bozelka B; Lane JT
Clin Immunol Immunopathol; 1986 Apr; 39(1):112-20. PubMed ID: 3485020
[TBL] [Abstract][Full Text] [Related]
18. Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals.
Modica MA; Zambito AM; Candore G; Caruso C
Immunobiology; 1990 Nov; 181(4-5):257-66. PubMed ID: 2129202
[TBL] [Abstract][Full Text] [Related]
19. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.
Godot V; Harraga S; Beurton I; Tiberghien P; Sarciron E; Gottstein B; Vuitton DA
Clin Exp Immunol; 2000 Sep; 121(3):491-8. PubMed ID: 10971516
[TBL] [Abstract][Full Text] [Related]
20. Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity.
Lio D; Candore G; Romano GC; D'Anna C; Gervasi F; Di Lorenzo G; Modica MA; Potestio M; Caruso C
Cytokines Cell Mol Ther; 1997 Dec; 3(4):217-24. PubMed ID: 9740350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
